Lijie Xing Selected Research

Lijie Xing Research Topics

Disease

13	Multiple Myeloma 02/2024 - 11/2017
7	Neoplasms (Cancer) 04/2023 - 01/2020
2	Bites and Stings (Sting) 12/2021 - 06/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	B-Cell Prolymphocytic Leukemia 01/2022
1	Genomic Instability 01/2020
1	Infections 03/2013

Drug/Important Bio-Agent (IBA)

7	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2023 - 01/2020
4	daratumumabIBA 02/2024 - 11/2017
4	Monoclonal AntibodiesIBA 02/2024 - 11/2017
4	Immunoconjugates (Immunoconjugate)IBA 04/2023 - 01/2020
4	Bortezomib (Velcade)FDA Link 01/2022 - 01/2020
4	Immunomodulating AgentsIBA 01/2021 - 01/2019
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2019
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2022
2	Chimeric Antigen ReceptorsIBA 12/2021 - 06/2020
2	AntigensIBA 12/2021 - 11/2020
2	elotuzumabIBA 12/2021 - 11/2017
2	pomalidomideIBA 01/2020 - 01/2019
1	Cytotoxins (Cytolysins)IBA 04/2023
1	Gemcitabine FDA Link 01/2022
1	zanubrutinibIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Thalidomide (Thalomid)FDA Link 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	Bispecific AntibodiesIBA 01/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	B-Cell Maturation AntigenIBA 12/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	LigandsIBA 10/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 06/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	UbiquitinIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Ligases (Synthetase)IBA 01/2019
1	Complement System Proteins (Complement)IBA 11/2017
1	Plant ExtractsIBA 03/2013
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 03/2013

Therapy/Procedure

4	Therapeutics 04/2023 - 06/2020
4	Immunotherapy 12/2021 - 11/2017
2	Immunomodulation 12/2021 - 01/2020